With Tru-D, we found a company that not only shares our values, but also our mission to develop innovative technologies that make a real difference to healthcare professionals and patients." "In looking to address the needs of Environmental Service Professionals, we identified Tru-D SmartUVC as an opportunity to provide a more integrated, data-driven product solution. "Investing in a broader array of infection prevention products and solutions is a critical element of PDI's strategy and a vital element of our service to patients and customers," said Kent Davies, President and Chief Operating Officer, PDI. difficile, in any environment. In combination with highly compliant manual disinfection that included the use of surface disinfectant wipes, the CDC-funded Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study showed Tru-D was able to reduce the relative risk of colonization and infection among patients in hospital settings. UVC energy has been shown to be an effective and eco-friendly way to reduce the risk of dangerous microorganisms, including C. difficile) is one of the most deadly and hard-to-kill microorganisms that is most commonly found in healthcare environments. Of these HAIs, Clostridioides difficile (C. Healthcare-associated infections (HAIs) affect approximately 1 in 31 hospital patients, with an associated 72,000 deaths in the US annually i. "The acquisition of Tru-D is among our most recent efforts supporting our continued mission to reduce preventable infections, control associated costs, and ultimately help save lives across the healthcare continuum of care." "We are proud of our 40-year legacy in assisting the healthcare industry with products and solutions that help reduce the risk of infections," said Zachary T.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |